METTL3 and esophageal squamous cell carcinoma: Mechanistically, METTL3 promoted ESCC development and reduced chemosensitivity to PTX through regulating the mRNA stability of apoptosis-related genes caspase 9 (CASP9) and apoptosis protein repeat-containing 3 (BIRC3).